Zobrazeno 1 - 10
of 654
pro vyhledávání: '"Timothy R, Rebbeck"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Multiple myeloma (MM) is a plasma cell disorder accounting for approximately 10% of hematologic malignancies. There is limited epidemiological evidence regarding the long-term trends and disparities in MM in the US. We conducted a multiple t
Externí odkaz:
https://doaj.org/article/8e8a4a22642f42e88861043938034bdc
Autor:
Abraham C. van Wyk, Priti Lal, J. Olufemi Ogunbiyi, Lynnette Kyokunda, Fred Hobenu, Cherif Dial, Mohamed Jalloh, Richard Gyasi, Olabode P. Oluwole, Afua D. Abrahams, Adam R. Botha, Nompumelelo Zamokuhle Mtshali, Caroline Andrews, Sunny Mante, Ben Adusei, Serigne M. Gueye, James E. Mensah, Andrew Anthony Adjei, Yao Tettey, Akin Adebiyi, Oseremen Aisuodionoe-Shadrach, Sefiu Bolarinwa Eniola, Amparo Serna, Kosj Yamoah, Wenlong Carl Chen, Pedro Fernandez, Brian D. Robinson, Juan Miguel Mosquera, Ann W. Hsing, Ilir Agalliu, Timothy R. Rebbeck
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEProstate cancer disproportionately affects men of African descent, yet their representation in tissue-based studies is limited. This multinational, multicenter pilot study aims to establish the groundwork for collaborative research on prostate
Externí odkaz:
https://doaj.org/article/ed0d1870ce6c4a4b9b1ca9f94f1c5c6d
Autor:
Yoanna S. Pumpalova, Adarsh Ramakrishnan, Michael May, Audrey Pentz, Shauli Minkowitz, Sean Doherty, Elvira Singh, Wenlong Carl Chen, Timothy R. Rebbeck, Alfred I. Neugut, Maureen Joffe
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Men of African descent are disproportionately affected by prostate cancer (PCa), and many have metastatic disease at presentation. In South Africa (SA), androgen deprivation therapy (ADT) is the first‐line treatment for stage IV
Externí odkaz:
https://doaj.org/article/a50e4ba43a974a2db21b1c7d599ad163
Autor:
Nathan Oehrlein, Samantha A. Streicher, Huai‐Ching Kuo, Avinash Chaurasia, Jacob McFadden, Darryl Nousome, Yongmei Chen, Sean P. Stroup, John Musser, Timothy Brand, Christopher Porter, Inger L. Rosner, Gregory T. Chesnut, Kayla C. Onofaro, Timothy R. Rebbeck, Anthony D’Amico, Grace Lu‐Yao, Jennifer Cullen
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4354-4365 (2022)
Abstract Background There is substantial variability in prostate cancer (PCa) mortality rates across Caucasian American (CA), African American (AA), Asian, and Hispanic men; however, these estimates are unable to disentangle race or ethnicity from co
Externí odkaz:
https://doaj.org/article/80095399a5ba4aa5b4182ef949372bbf
Autor:
Michelle S. Kim, Daphne Naidoo, Ujani Hazra, Melanie H. Quiver, Wenlong C. Chen, Corinne N. Simonti, Paidamoyo Kachambwa, Maxine Harlemon, Ilir Agalliu, Shakuntala Baichoo, Pedro Fernandez, Ann W. Hsing, Mohamed Jalloh, Serigne M. Gueye, Lamine Niang, Halimatou Diop, Medina Ndoye, Nana Yaa Snyper, Ben Adusei, James E. Mensah, Afua O. D. Abrahams, Richard Biritwum, Andrew A. Adjei, Akindele O. Adebiyi, Olayiwola Shittu, Olufemi Ogunbiyi, Sikiru Adebayo, Oseremen I. Aisuodionoe-Shadrach, Maxwell M. Nwegbu, Hafees O. Ajibola, Olabode P. Oluwole, Mustapha A. Jamda, Elvira Singh, Audrey Pentz, Maureen Joffe, Burcu F. Darst, David V. Conti, Christopher A. Haiman, Petrus V. Spies, André van der Merwe, Thomas E. Rohan, Judith Jacobson, Alfred I. Neugut, Jo McBride, Caroline Andrews, Lindsay N. Petersen, Timothy R. Rebbeck, Joseph Lachance
Publikováno v:
Genome Biology, Vol 23, Iss 1, Pp 1-16 (2022)
Abstract Background Genome-wide association studies do not always replicate well across populations, limiting the generalizability of polygenic risk scores (PRS). Despite higher incidence and mortality rates of prostate cancer in men of African desce
Externí odkaz:
https://doaj.org/article/2fb0ba33d74e488caec70d594a0a5e30
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-9 (2022)
Abstract Carriers of germline BRCA2 pathogenic sequence variants have elevated aggressive prostate cancer risk and are candidates for precision oncology treatments. We examined whether BRCA2-deficient (BRCA2 d ) prostate tumors have distinct genomic
Externí odkaz:
https://doaj.org/article/e8bd40b686474509a6110e6ca54a55c3
Autor:
Kevin H. Kensler, Shivanshu Awasthi, Mohamed Alshalalfa, Bruce J. Trock, Stephen J. Freedland, Michael R. Freeman, Sungyong You, Brandon A. Mahal, Robert B. Den, Adam P. Dicker, R. Jeffrey Karnes, Eric A. Klein, Priti Lal, Yang Liu, Elai Davicioni, Walter Rayford, Kosj Yamoah, Timothy R. Rebbeck
Publikováno v:
European Urology Open Science, Vol 40, Iss , Pp 19-26 (2022)
Background: Socioeconomic and health care utilization factors are major drivers of prostate cancer (PC) mortality disparities in the USA; however, tumor molecular heterogeneity may also contribute to the higher mortality among Black men. Objective: T
Externí odkaz:
https://doaj.org/article/0f6271a5f96f4db29f8e1ec6aede759a
Autor:
Chong Wu, Jingjing Zhu, Austin King, Xiaoran Tong, Qing Lu, Jong Y. Park, Liang Wang, Guimin Gao, Hong‐Wen Deng, Yaohua Yang, Karen E. Knudsen, Timothy R. Rebbeck, Jirong Long, Wei Zheng, Wei Pan, David V. Conti, Christopher A Haiman, Lang Wu
Publikováno v:
Cancer Communications, Vol 41, Iss 12, Pp 1387-1397 (2021)
Abstract Background DNA methylation and gene expression are known to play important roles in the etiology of human diseases such as prostate cancer (PCa). However, it has not yet been possible to incorporate information of DNA methylation and gene ex
Externí odkaz:
https://doaj.org/article/79475d2918494b0fb8bc2bb0ecbffd04
Autor:
Tara M. Friebel-Klingner, Lisa Bazzett-Matabele, Doreen Ramogola-Masire, Barati Monare, Tlotlo B. Ralefala, Alexander Seiphetlheng, Gaobakwe Ramontshonyana, Peter Vuylsteke, Nandita Mitra, Douglas J. Wiebe, Timothy R. Rebbeck, Anne Marie McCarthy, Surbhi Grover
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSECervical cancer is the leading cause of cancer death for women in Botswana. Barriers in access to cancer care can lead to later stages at diagnosis and increased mortality. This study evaluated access, defined as travel time from a patient's r
Externí odkaz:
https://doaj.org/article/3ae643fc1179436289a40a4fb2339ee3
Autor:
Parsa Erfani, Michael Bates, Pat Garcia-Gonzalez, Dan A. Milner, Timothy R. Rebbeck, Deogratias Ruhangaza, Lawrence N. Shulman, Temidayo Fadelu
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/51139f8568d545e2941bb4de56664eb1